Aurobindo to expand product basket; eyes $3bn revenues by FY18

The company has several levers to gain traction with a robust business model, a large differentiated product portfolio that addresses six key therapeutic areas and a growing presence in over 150 countries.

Aurobindo Pharma CEO Arvind Vasudeva resigns

Recently, the drug firm had said that it intends to invest up to Rs 900 crore this fiscal on various activities including capacity expansion, clinical trials and product filings.

Aurobindo gets USFDA nod to sell antibiotic oral suspension

The approval by the USFDA is for strengths of 100 mg/5 ml and 200 mg/5 ml and the product is ready for launch, Aurobindo Pharma said in a statement.

Aurobindo divests Australian arm to Eris Pharma

Aurobindo Pharma has divested stake in its Australian subsidiary to Eris Pharma for an undisclosed amount to focus on the US, European and emerging markets.

Plethico shares soar 20% on settlement pact with Aurobindo

Shares of Plethico Pharmaceuticals zoomed 20 percent Thursday after reaching settlement with Aurobindo Pharma related to the acquisition of US-based Natrol.

Aurobindo gets USFDA nod for Atracurium Besylate injections

Drug major Aurobindo Pharma has received final approval from the US health regulator to manufacture and market Atracurium Besylate injections in the American market.

Plethico to pay Aurobindo Pharma $23.3 mn to settle dispute

Aurobindo Pharma on Thursday said Plethico will pay it USD 23.3 million to settle a dispute related to the acquisition of US-based Natrol.

CCEA clears Glenmark, Aurobindo proposals worth Rs 4,187 cr

Pharmaceutical majors Glenmark and Aurobindo's foreign investment proposals, worth Rs 4,187 crore, were approved by the government Tuesday.

Aurobindo gets tentative nod from USFDA for Lacosamide tablets

Drug firm Aurobindo Pharma has received tentative approval from the US health regulator USFDA for its generic Lacosamide tablets used in treatment of partial seizures in epilepsy patients.

Cos raise over $4-bn from QIP in FY15; $3-bn more in pipeline

Indian companies have raised over USD 4 billion (Rs 27,000 crore) from Qualified Institutional Placement (QIP) of shares so far in the current fiscal, while plans are underway to garner further funds worth an estimated USD 3 billion through this route.

Aurobindo Pharma to raise $350 million through QIP

Aurobindo Pharma Limited on Thursday said the company will raise up to USD 350 million by way of Qualified Institutions Placement (QIP).

Aurobindo, Lupin & Jubilant get USFDA nod for hypertension drug

Three domestic firms, Aurobindo Pharma, Lupin and Jubilant Life Sciences, have received final approval from US health regulator to sell generic copies of Valsartan tablets used for treatment of hypertension.

Constable, suspect in pharma tycoon kidnapping bid, nabbed

Police have picked up a constable of Andhra Pradesh Special Police (APSP), who had once worked with anti-Naxal Greyhounds force, in connection with yesterday's failed attempt to abduct vice-chairman of Aurobindo Pharma K Nityananda Reddy.

Bid to kidnap top pharma company official at gun-point

An AK-47 rifle wielding man allegedly tried to abduct Aurobindo Pharma's Director K Nityananda Reddy from his car near a park and opened fire when Reddy and his brother resisted in the posh Banjara Hills this morning.

Firing by unidentified assailants in Hyderabad

K Nityananda Reddy, vice chairman and director of pharmaceuticals firm Aurobindo Pharma, was shot at here on Wednesday morning by unidentified assailants, reports said.

Pharma company chairman shot at in early morning attack in Hyderabad

K Nityananda Reddy, vice chairman and director of pharmaceuticals firm Aurobindo Pharma, was shot at here on Wednesday morning by unidentified assailants, reports said.

Aurobindo Pharma may spend Rs 1,300 cr toward capex in FY15-16

Drug maker Aurobindo Pharma Limited may spend up to Rs 1,300 crore towards capex during the ongoing and next financial years.

MSCI adds Aurobindo Pharma to India index

The MSCI Global Standard Indices will see the addition of Aurobindo Pharma with effect from May 30.

Three hurt in minor explosion at Aurobindo Pharma plant in AP

Three contract workers were injured in a minor blast at Aurobindo Pharma unit at Pydibheemavaram near here in Andhra Pradesh on Friday, police said.

Aurobindo Pharma to acquire Activis' ops in 7 European nations

Generic drug maker Aurobindo Pharma has signed a binding offer agreement to acquire commercial operations of Dublin-based Actavis plc in seven Western European countries.